Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call | ||
By: GlobeNewswire - 08 Aug 2022 | Back to overview list |
|
August 8, 2022 BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call COPENHAGEN, DENMARK and BOSTON, MA, USA, August 8, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury, announced today that in connection with the release of its Interim Report for the second quarter of 2022, the Company’s management team will host an online investor presentation on August 17, 2022 at 14:00 Central European Time / 8:00 Eastern Time via HC Andersen Capital. Investors interested in attending the webcast may register at: A separate analyst call will be held on August 17, 2022 at 16:00 Central European Time / 10:00 Eastern Time, with details as follows: Denmark: +45 8025 1917 Investor Relations Contacts Tim Eriksen, EU Investor Relations, Zenith Advisory, +45 4529 0000, investor@bioporto.com About BioPorto The Company’s flagship product is The NGAL Test, which has been designed to aid in the risk assessment of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality if not identified and treated early. With the aid of The NGAL Test, physicians can identify patients potentially at risk of AKI more rapidly than is possible with current standard of care measurements, enabling earlier intervention and more tailored patient management strategies. The NGAL Test is CE marked and registered in a number of countries worldwide. BioPorto has facilities in Copenhagen, Denmark and Boston, MA, USA. The shares of BioPorto A/S are listed on the Nasdaq Copenhagen stock exchange. For more information visit www.bioporto.com.
Attachment |
||
|
||
Copyright 2022 GlobeNewswire | Back to overview list |